Table 5.
Comparison of antimicrobial resistance profiles of 25 ESBL and 28 non ESBL isolates
| Antimicrobial agent | Bacterial resistant patterns | p value | |
|---|---|---|---|
| ESBL (n = 25) | Non ESBL (n = 28) | ||
| n (%) | n (%) | ||
| AMP | 25 (100.0) | 28 (100.0) | - |
| C | 7 (28.0) | 2 (7.1) | 0.067* |
| AMC | 25 (100.0) | 23 (82.1) | 0.053* |
| CTR | 25 (100.0) | 0 (0.0) | <0.001* |
| CAZ | 25 (100.0) | 2 (7.1) | <0.001* |
| CO | 24 (96.0) | 17 (60.7) | 0.003* |
| GE | 4 (16.0) | 4 (14.3) | 1.000 |
| CIP | 4 (16.0) | 0 (0.0) | 0.043* |
| MEM | 0 (0.0) | 0 (0.0) | - |
ESBL extended spectrum beta lactamase producer, AMP ampicillin, C chloramphenicol, AMC amoxycillin-clavulanate, CTR ceftriaxone, CAZ ceftazidime, CO trimethoprim – sulfamethoxazole, GE gentamicin, CIP ciprofloxacin, MEM meropenem, n number of resistant bacterial species
*Fisher’s exact